Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Burnham SC, et al. Mol Psychiatry. 2014 Apr;19(4):519-26. doi: 10.1038/mp.2013.40. Epub 2013 Apr 30. Mol Psychiatry. 2014. PMID: 23628985
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD; AIBL Research Group. Rembach A, et al. Among authors: burnham sc. J Alzheimers Dis. 2014;40(1):95-104. doi: 10.3233/JAD-131802. J Alzheimers Dis. 2014. PMID: 24334723
MR-less surface-based amyloid assessment based on 11C PiB PET.
Zhou L, Salvado O, Dore V, Bourgeat P, Raniga P, Macaulay SL, Ames D, Masters CL, Ellis KA, Villemagne VL, Rowe CC, Fripp J; AIBL Research Group. Zhou L, et al. PLoS One. 2014 Jan 10;9(1):e84777. doi: 10.1371/journal.pone.0084777. eCollection 2014. PLoS One. 2014. PMID: 24427295 Free PMC article.
Influence of BDNF Val66Met on the relationship between physical activity and brain volume.
Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, Masters CL, Maruff P, Martins RN; AIBL Research Group. Brown BM, et al. Neurology. 2014 Oct 7;83(15):1345-52. doi: 10.1212/WNL.0000000000000867. Epub 2014 Sep 3. Neurology. 2014. PMID: 25186863
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.
Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, Martins RN; AIBL Research Group. Gupta VB, et al. Alzheimers Res Ther. 2015 Feb 20;7(1):16. doi: 10.1186/s13195-015-0105-6. eCollection 2015. Alzheimers Res Ther. 2015. PMID: 25859282 Free PMC article.
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, Narayan VA; Alzheimer’s Disease Neuroimaging Initiative; AIBL Research Group. Burnham SC, et al. J Alzheimers Dis. 2015;46(4):1079-89. doi: 10.3233/JAD-143015. J Alzheimers Dis. 2015. PMID: 26402634
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group. Burnham SC, et al. Lancet Neurol. 2016 Sep;15(10):1044-53. doi: 10.1016/S1474-4422(16)30125-9. Epub 2016 Jul 20. Lancet Neurol. 2016. PMID: 27450471
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, Villemagne VL. Burnham SC, et al. Neurology. 2016 Sep 13;87(11):1093-101. doi: 10.1212/WNL.0000000000003094. Epub 2016 Aug 17. Neurology. 2016. PMID: 27534714
83 results